Fletcher Allen, a Vermont university hospital and medical center, serves all of
Vermont and the northern New York region. Located in Burlington, Fletcher Allen is a regional, academic healthcare center and teaching hospital in alliance with the University of Vermont.
Ischemic Heart Disease
- Cardiology
- 62 Tilley Drive
South Burlington, VT 05403 - Phone: 802-847-4600
- Fax: 802-847-2533
- Monday-Friday, 8AM-5PM
- Directions
Ischemic heart disease refers to conditions in which heart muscle is damaged or works inefficiently because of an inadequate flow of blood to the heart.
It is a very common condition in the United States. Each year, more than one million people suffer a heart attack, and more than 16 million are diagnosed with angina, or chest pain. In addition to being widespread, ischemic heart disease is the leading single cause of death in the United States: it is responsible for 1 of every 4.8 deaths.
The treatment of ischemic heart disease focuses on two areas:
1) prevention of myocardial infarction and death
2) reduction of symptoms and occurrence of ischemia to improve quality of life
Although all University Cardiology Associates treat patients with ischemic heart disease, selected members of our group focus on refining current therapy and defining the valve for novel treatment options.
Members of our invasive cardiology group participate in the development of new therapeutic options for percutaneous coronary interventions such as drug eluting stents.
Members of the preventive cardiology group and vascular biology group are actively engaged in defining mechanisms responsible for myocardial infarction as well as more effective methods to prevent these events.
The cardiac rehabilitation unit seeks to improve recovery after cardiac events. The cardiac imaging group focuses on defining the extent and functional implications of ischemic heart disease. A particular strength of our group is in defining the role and treatment of thrombosis in ischemic heart disease.
